CXCL12 and breast cancer: Anti-angiogenic effect of miR-7 is mediated by targeting chemokine receptors CXCR4 and CXCR7 in BC, which are receptors for the stromal cell-derived factor-1 alpha (SDF-1α)/ CXCL12 chemokines [56].